Fundz

Dexcare Closes $75M In Series C Funding, Led By Iconiq Growth, To Accelerate Market Expansion Of Its Care Access Platform

PRIVATEJun 21, 2023

Amount Raised

$75 Million

Round Type

Series C

SeattleHealthcareSoftwareHealth Care

Investors

ICONIQ Growth

Description

DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access. The new funding brings the total raised to $146 million, including two oversubscribed rounds closed in less than two years.

Quick answer

DexCare raised $75 Million in a Series C round, dated June 21, 2023. Investors: ICONIQ Growth. DexCare is based in Seattle, Washington, United States.

How much did DexCare raise?
DexCare raised $75 Million in a Series C round on June 21, 2023.
Who invested in DexCare?
ICONIQ Growth is named as investors in this round.
What does DexCare do?
DexCare is a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care.
Where is DexCare based and how big is it?
DexCare is based in Seattle, Washington, United States. Fundz records about 131 employees.
Who are the decision-makers at DexCare?
Fundz holds 3 contacts at DexCare, including the Chief Product Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Software around the same time

Companies in the same sectors as DexCare that raised within 45 days of this round, from Fundz verified event records.

  • Streamex Corp. raised $2.2M (Seed) on July 31, 2023.
  • RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
  • Streamex Corp. raised $495K (Seed) on July 19, 2023.
  • Streamex Corp. raised $1.7M (Seed) on June 30, 2023.
  • Ospitek raised $5.4M on June 27, 2023.
  • Nivagen Pharmaceuticals raised $5M on June 16, 2023.

Who to call at DexCare, and when

A new round usually means DexCare is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DexCare raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DexCare, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DexCare. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DexCare

Location

Seattle, Washington, United States

About

DexCare is a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care. In a complex and vast sea of virtual point solutions, DexCare is the operating system that makes it all work. DexCare's data-driven intelligence engine allocates, flexes and optimizes resources to best meet both consumer demand and health system business goals—expanding the reach of health system service lines into a new, digital and on-demand consumer arena. The platform attracts and caters to high-value consumers by providing a fully-digitized, unified experience that routes consumers to the best care options while leveraging existing EMR, caregiver and brand investments. Incubated at Providence, one of the nation's largest and most innovative health systems, DexCare has enabled service lines to attract 30% more new patients, capture 5x downstream revenue, generate 22% per patient encounter in costs savings, and deliver a net promoter satisfaction score greater than 90.DexCare customers include leading health systems across the U.S. For more information, visit dexcarehealth.com or follow us on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DexCare raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsRakshay J., Chief Product Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DexCare's next move

See what Strategic adds

DexCare raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.